The STI qPCR Assay is a highly advanced diagnostic tool developed to address the challenges of detecting STI pathogens. STIs have a profound impact on sexual and reproductive health worldwide, with The World Health Organization (WHO) stating more than 1 million curable STIs are acquired every day. An estimated 374 million new infections of chlamydia, gonorrhoea, syphilis and trichomoniasis are detected annually, highlighting the importance of rapid detection and treatment of STIs to prevent further spread.
The STI qPCR assays are available as four separate kits, offering increased flexibility, facilitating the sensitive detection of 9 pathogens. Each STI-X assay uses the same PCR cycling conditions allowing for multiple assays to be run on the same instrument simultaneously. With only 2 components required for the mastermix, the STI qPCR assays offer the ultimate in efficiency, helping to streamline the laboratory workflow.
- Specifically validated for QuantStudio™ 5 Real-Time PCR systems.
- Kit format supports up to 96 samples, varying batch sizes for maximum flexibility.
- Internal control included to prevent false negatives and ensure successful DNA extraction and PCR.
- Validated for a range of sample matrices including urine and urogenital swabs.
- Efficient workflow optimised for laboratory efficiency. PCR run time of less than 65 minutes.
- Assays available in four separate kits for increased flexibility as per laboratory requirements.
- QP10704: CT/NG fleX qPCR Assay - 96 Tests